February 10, 2025 03:50 PM EST
R&D
Pharma

Mer­ck KGaA con­firms in­ter­est in ac­quir­ing can­cer biotech Spring­Works

Max Bayer

Pharma Reporter

Ger­man phar­ma com­pa­ny Mer­ck KGaA con­firmed that it is in talks to ac­quire Spring­Works Ther­a­peu­tics, though a deal has yet to be an­nounced.

Mer­ck …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Up­dat­ed: White House pulls Wel­don's nom­i­na­tion to lead CDC at last minute

Up­dat­ed: En­do and Mallinck­rodt to merge in $6.7B deal

Am­gen re­ports more Up­liz­na da­ta in myas­the­nia gravis ahead of FDA fil­ing

Trump blog: FDA, NIH picks clear Sen­ate pan­el; CDC nom­i­nee pulled at last minute

MeiraGTx teams with cryp­tic AI start­up, co-found­ed by Er­ic Schmidt, to ad­vance Parkin­son's gene ther­a­py

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times